Procedure guideline for gallium scintigraphy in the evaluation of malignant disease. Society of Nuclear Medicine.

PART VII: CONCISE BIBLIOGRAPHY 1. Datz, FL. The current status of radionuclide infection imaging. In: Freeman LM, ed. Nuclear medicine annual. New York: Raven Press, Ltd; 1993:47-76. (General reference.) 2. Kipper SL. Radiolabeled leukocyte imaging of the ab domen. In: Freeman LM, ed. Nuclear medicine annual. New York: Raven Press, Ltd; 1995:81-128. (General overview.) 3. Peters AM. The utility of 99mTc HMPAO-leukocyte for imaging infection. Semin NucA-Med 1994;24:92-109. (Clinical overview.) 4. Amdt JW, Veer A, BlA¶kD, et al. Prospective compara tive study of technetium-99m-WBCs and indium-111granulocytes for the examination of patients with inflam matory bowel disease. J NucA-Med 1993;34:1052-1057. (Clinical comparison study.) 5. Carpani de Kaski M, Peters AM, Knight D, et al. Quantitation of bowel inflammation. J NucA-Med 1992; 33:756-762. 6. Paavola PC, Carremon FL, Thorson LM, et al. Optimal storage temperatures and times for indium-lll-oxine labeled leukocytes. J NucA-Med Techno! 1995;23:126. 7. Danpure HJ, Osman S, Carroll MJ. Development of a clinical protocol for radiolabeling of mixed leukocytes with 99mTc-hexamethylpropylenamine oxime. NucA-Med Commun 1988;9:465-475. (Labeling technique.) 8. Dewanjee MK. The chemistry of Tc-99m-labeled radiopharmaceuticals. Semin NucA-Med 1990;20:5-7. (Label ing technique.) 9. Mortelmans L, Malbrain S, Stuyck J, et al. In vitro and in vivo evaluation of granulocyte labeling with (99mTc)d,lHMPAO. J NucA-Med 1989;30:2022-2028. (Labeling technique.) 10. Brown ML, Hung JC, Vetter RJ, et al. The radiation dosimetry and normal value study of 99mTc-HMPAOlabeled leukocytes. Invest Radial 1994;29:443-447. 11. McAfee JG. What is the best method for imaging focal infections? J NucA-Med 1990;31:413-416. (Overview of labeling techniques.) 12. Reynolds JH, Graham D, Smith FW. Imaging inflamma tion with 99mTc-HMPAO-labeled leukocytes. Clin Ra diai 1990;42:195-198. (Clinical results.) 13. Roddie ME, Peter AM, Danpure HJ, et al. Inflammationimaging with 99mTc-HMPAO-labeled leukocytes. Radi ology 1988; 166:767-772. (Clinical results.)

[1]  P. Hoffer,et al.  Gallium scans in patients with mediastinal Hodgkin's disease treated with chemotherapy. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  R. Sephton,et al.  Modification of distribution of gallium 67 in man by administration of iron. , 1980, British Journal of Radiology.

[3]  R. Henkin,et al.  Scanning treated Hodgkin's disease with 67Ga citrate. , 1974, Radiology.

[4]  D Front,et al.  Ga-67 SPECT before and after treatment of lymphoma. , 1990, Radiology.

[5]  P. Stomper,et al.  Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  V. R. McCready,et al.  A comparison of gallium-67 single photon emission computed tomography and computed tomography in mediastinal Hodgkin's disease. , 1992, European journal of cancer.

[7]  L. Balzarini,et al.  Current role of gallium scan and magnetic resonance imaging in the management of mediastinal Hodgkin lymphoma , 1993, Cancer.

[8]  O. Israel,et al.  Gallium-67 uptake in a mass of benign transformation mimicking recurrence of nodular lymphocytic predominance Hodgkin's disease. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  J. Bourhis,et al.  Gallium scan in the evaluation of post chemotherapy mediastinal residual masses of aggressive non-Hodgkin's lymphoma. , 1999, Leukemia & lymphoma.

[10]  S. Pileri,et al.  Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patients. , 1999, Blood.

[11]  I. Magrath,et al.  High frequency of benign mediastinal uptake of gallium-67 after completion of chemotherapy in children with high-grade non-Hodgkin's lymphoma. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  L. Prosnitz,et al.  Prognostic importance of restaging gallium scans following induction chemotherapy for advanced Hodgkin's disease. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  P. Rehm.  Gallium-67 scintigraphy in the management: Hodgkin's disease and non-Hodgkin's lymphoma. , 1999, Cancer biotherapy & radiopharmaceuticals.

[14]  M A King,et al.  Effect of filtering on the detection and localization of small Ga-67 lesions in thoracic single photon emission computed tomography images. , 1999, Medical physics.

[15]  R. E. Zimmerman,et al.  GALLIUM-67 IMAGE CONTRAST: RELATIONSHIP TO ENERGY PEAK AND WINDOW WIDTH SELECTION , 1995 .

[16]  J. Delville,et al.  CD71 phenotype and the value of gallium imaging in lymphomas , 1991, American journal of hematology.

[17]  W. Raynor,et al.  Cleansing the colon in gallium-67 scintigraphy: a prospective comparison of regimens. , 1981, AJR. American journal of roentgenology.

[18]  J. Kereiakes,et al.  Radiation absorbed-dose estimates for the liver, spleen, and metaphyseal growth complexes in children undergoing gallium-67 citrate scanning. , 1983, Radiology.

[19]  G. Canellos,et al.  High-dose gallium imaging in lymphoma. , 1983, The American journal of medicine.

[20]  P. Gallé,et al.  Mechanism involved in gallium-67 (Ga-67) uptake by human lymphoid cell lines. , 1998, Cellular and molecular biology.

[21]  F. Gherlinzoni,et al.  Diagnostic role of gallium scanning in the management of lymphoma with mediastinal involvement. , 1999, Haematologica.

[22]  P. Hoffer,et al.  The role of gallium-67 in the clinical evaluation of cancer. , 1984, Seminars in nuclear medicine.

[23]  S. M. Shaw,et al.  Detection of Drug Interactions Involving Radiopharmaceuticals: A Professional Responsibility of the Clinical Pharmacist , 1989 .

[24]  O. Israel,et al.  Benign mediastinal and parahilar uptake of gallium-67 in treated lymphoma: do we have all the answers? , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  A. Belch,et al.  Does gallium uptake in the pulmonary hila predict involvement by non-Hodgkin's lymphoma? , 1992, Nuclear medicine communications.